chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a healthcare worker regarding an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patient were vaccinated with improperly stored GARDASIL 9 lot # M004116/ expiration date- 12-OCT-2017 (incorrect product storage). No concomitant medication was reported. No adverse event. It was exposed to temperature of 75.5F for 3 hour 7 minutes. Previously it was not exposed to temperature excursion. The call was because of a data logger. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. The outcome of event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
A nurse reported that a 9 year old male experienced left nare closed. and multiple violent sneezing of about 15-20 times immediately after FluMist vaccine on 10/19/2005. There was no additional information at the time of report. The patients clinical outcome in unknown. Reporter causality is not provided. A nurse reported that a 9-year-old male experienced "left rare clomire" and multiple episodes of violent sneezing approximately 15-20 times immediately after receiving FLUMIST vaccine on 18Oct2005. The patient's clinical outcome is unknown. Reporter causility is not provided. 26Apr2006: Additional information received include date of birth, lot number and expiration date of vaccine.
Periodic uterine & ovary pain that started after the night of the second shot. It is now periodic (happening mid-cycle) and lasts a few hours
Date given 1/7/13 reaction on 1/8/13 extreme edema at inj. site with 102 degree fever. No treatment given Mom didn't notify our office until 1/18/13 & reaction imp. within 24 hours.
Initially I did not think that patient had a Havrix dose previously. I searched in records and did not find her profile. She also could not remember if she had it before. Afterwards, I looked again and found out she had a dose in August.
This is a spontaneous report from a contactable other health care professional reported that. A 42-years-old non-pregnant female patient received dose 1 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Left Arm on 04Mar2021 at 11:15 (at the age of 42-years old) as single dose for COVID-19 immunization. The Medical history included none. The patient's concomitant medications were not reported. The patient previously took Levaquin (Levocetirizine) and experienced allergy. The patient has not suffered from COVID-19 prior vaccination. The patient had not done COVID tested post vaccination. Patient has not received other vaccine in four weeks. 2 days after 1st dose, on 06Mar2021 at 06:00 AM, the patient reported my skin was very itchy, mostly around chest, neck and face, but day 3 the itchy sensation turned into a slight itchy burning sensation in same areas of body, took a Benadryl and it went away, by day 4, same burning sensation but now in hands and arms, went to Dr and he told, had some hives. The patient received treatment for the events. Prescribed Levocetirizine 5g for a week and also advised to take OTC Zyrtec after week daily for allergies. Patient do not suffer from allergies nor have ever had a reaction to a vaccine before. The outcome for the events skin was very itchy, mostly around chest, neck and face, but day 3 the itchy sensation turned into a slight itchy burning sensation in same areas of body, sensation but now in hands and arms, hives were recovering. No follow-up attempts are possible. No further information is expected.
Patient was given an expired vaccination.  Expiration date of 07/31/2022.  Patient was notified at the time of visit, she was feeling fine when she was discharged from the visit today.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 78-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Oct2022 as dose 5 (booster), single (Lot number: GH9703), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 07Feb2021 as dose 1, single (Lot number: EM9809), in left arm, on 01Mar2021 as dose 2, single (Lot number: EN1203), in left arm and on 29Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Prostate cancer" (unspecified if ongoing); "known allergies: Sulpha drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (09Feb2023) Positive, notes: Tested positive for Covid 4 days after the 5 day Pavlovid treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19 (PAXLOVID Treatment).
This spontaneous report was received from a medical assistant regarding to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 10-MAY-2018, the patient received an improperly stored dose of ROTATEQ taken orally (lot # N011651 and expiration date 02-DEC-2018)(dose, strength and frequency were not provided) for prophylaxis. The vaccines experienced a temperature excursion of 47 degrees Fahrenheit (F) to 77 degrees Fahrenheit (F) (60.33 degree F) for a time frame of 42 hours. It was reported that there was no previous temperature excursion and no adverse effect was reported. It was reported that this call was due to a digital data logger. Furthermore, no product quality complaint (PQC) was reported. This is one of several reports from same source. Sender's Comments: US-009507513-1806USA012857: US-009507513-1807USA003053: US-009507513-1807USA003054: US-009507513-1807USA003055: US-009507513-1807USA003056: US-009507513-1807USA003057: US-009507513-1807USA003058: US-009507513-1807USA003059: US-009507513-1807USA003060: US-009507513-1807USA003061: US-009507513-1807USA003063: US-009507513-1807USA003064: US-009507513-1807USA003065: US-009507513-1807USA003066: US-009507513-1807USA003067: US-009507513-1807USA003068: US-009507513-1807USA003069: US-009507513-1807USA003177.
I had my vaccination on 02/23/2022. A couple weeks later I started to experience fevers headaches knee aches. It became worse and more painful. I saw an orthopedic tear who stated I had a meniscus tear and fluid 05/2022. I had enlarged infusion on that knee a week prior. My immunologist who stated I had inflammation and fluid in my both hands. I had noticed a lot of the symptoms started to come back off brain fog aches after being on the CUVITRU antibody replacement for a year. It was a couple weeks in 03/2022 and all those symptoms were coming back full force. I had to use crutches due to the pain in my knee. The doctor increased the dosage of the CUVITRU treatment but it is still not going fully away.
Pt was having slurred speech and went to ER on Sunday and was admitted for an acute CVA
Weezy, flushed, extremely painful to swallow, general maliase; symptoms are lessened after taking Benadryl. Taste buds seem burned for approximately 24 hours after symptoms commenced. Similar reaction occurred after receiving the flu vaccine three years ago.
Severe pain, discomfort  reoccuring 8 days later. A lot of pain when trying to lift arm above shoulder height, or trying to rotate arm.  Radiates slightly above injection site to shoulder.
Developed urticarial rash, erythema & swelling of face & ear lobes. No respiratory distress. Given epinephrine 1:1000 0.1 ML s/c Rash and swelling cleared - promptly.
Arm pain; joint aches; muscle pain; fever 1.6 degrees higher than normal.
Starting 4/19/21, I believed I had food poisoning from something I ate.  Diarrhea, weakness, fatigue, fever, and lightheaded.  This lasted 3 weeks; I visited a gastroenterologist.  Since, I?ve had lightheadedness, lethargy, and abdominal pain.  Weakness in my hands and overall tiredness.  I?ve done, CT scans or my abdomen, my head, ultrasound of my internal organs, glucose tolerance test,
Muscle aches; Slight fever; This spontaneous case was received on 20-Nov-2020 from other non-health professional via Communication (reference number: SEQW20-05327) with additional document received on 24-Nov-2020 (being processed together) and concerned a male patient of an unspecified age.  The patient's medical history and concomitant medications were not reported.  On an unspecified date in Oct-2019, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; dose, route of administration, indication, anatomical location: not reported) at the pharmacy. The batch number was not reported.  On the same day, the patient was vaccinated with non-company co-suspect varicella zoster vaccine (shingles vaccine) (brand not specified; dose, route of administration, indication, anatomical location: not reported) at the pharmacy. The batch number was not reported.  On an unspecified date in 2019, unknown amount of time after receiving influenza virus vaccine polyvalent and varicella zoster vaccine, the patient developed slight fever and muscle aches for a day or so.  On an unspecified date in 2019, the patient recovered from the events.  The reporter did not provide causality assessment.  Company comment: The events of 'muscle ache' and 'slight fever' are assessed as related to influenza virus vaccine polyvalent.; Sender's Comments: The events of 'muscle ache' and 'slight fever' are assessed as related to influenza virus vaccine polyvalent.
Incorrect influenza vaccine given. Patient is 66 years old and should have been given a high dose influenza vaccine but was given regular quadrivalent.
Patient came to the office for his first dose ever of the COVID vaccine (Initial series) and a coworker mistakenly gave him the COVID Moderna bi-valent booster instead.  Patient sat for 30 mins with no reaction at all. While he was waiting i contacted vaccine organization and the people that take care of vaccines to find out what to do next. Since he had Moderna the protocol is the immediately give him the Initial dose vaccine- no interval . Except we do not have that in stock in the office. Everything was explained to the patient and he understood and when we get the initial in stock he will come and get a dose
Patient was administered booster shot with the pediatric formulation of 0.5 ml; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient was administered booster shot with the pediatric formulation of 0.5 ml) and NO ADVERSE EVENT (No adverse event) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Patient was administered booster shot with the pediatric formulation of 0.5 ml) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient was administered booster shot with the pediatric formulation of 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Patient was administered booster shot with the pediatric formulation of 0.5 ml).    Concomitant medications was not provided. It was stated that 4 patients received the pediatric formulation of 0.5 mL as their booster doses instead of the Moderna COVID-19 vaccine, bivalent.Pharmacist asked what needs to be done for these patients. They should administered the bivalent vaccine now or wait and if they required to wait ,how long. Patients had not reported any adverse reactions at the time of reporting. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-644021, US-MODERNATX, INC.-MOD-2022-644022, US-MODERNATX, INC.-MOD-2022-644023 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-644021:(same reporter) US-MODERNATX, INC.-MOD-2022-644022:(same reporter) US-MODERNATX, INC.-MOD-2022-644023:(same reporter)
Consistent with Gullian-Barre. Limbs tingling and going numb, significant neck pain on injection side, arm pain continues from injection site, nausea, diarrhea.
Nurse was completing a child health immunization visit. Child was needing the Dtap, HIB, & Prevnar 13 today; Mother had declined the Flu & Covid-19 vaccines. I had my sticky note with the vaccines written on there that the child needed, & I'm unsure as to why I pulled  a Hep A vaccine to administer instead of the HIB. I checked my 3 vaccines in hand 2-3 times of the expiration date, etc., but it never dawned on me that I didn't have the HIB in my hand. I came into the clinic room & had the child to get prepped to receive the vaccines in the legs; the vaccines had been scanned in system, & no warning box was provided to alert me that Hep A was up to date; only a pop-up box for no allergy assessment. I later called the mother to inform her of the occurrence of what had happened after I realized later that afternoon what I had done & she verbalized understanding & reports no issues with the child at this time, I informed her that this Hep A dose would be considered invalid & that he would need another dose at the appropriate interval in 3 months or so. I told the mother that he would need to have another appt. scheduled to receive the HIB vaccine & she states she will call back in 1 week or so for child to receive.
Lethargic; Hives; diagnosed with Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with Covid-19), LETHARGY (Lethargic) and URTICARIA (Hives) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced COVID-19 (diagnosed with Covid-19). On an unknown date, the patient experienced LETHARGY (Lethargic) and URTICARIA (Hives). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, COVID-19 (diagnosed with Covid-19), LETHARGY (Lethargic) and URTICARIA (Hives) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: diagnosed with covid-19 (Positive) diagnosed with Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included Birth control pills. Prednisone was mentioned as a treatment medication.  Company Comment: This is a spontaneous case concerning a 24-year-old, female patient with no relevant medical history, who experienced the unexpected, non-serious, AESI event of COVID-19. The event occurred 1 week after the first dose of mRNA-1273 vaccine administered on an unknown date in Feb-21 for the indication of COVID-19 vaccination. SARS-CoV-2 test done on 15-Jun-21 was positive. At the time of report outcome of the event was Unknown. Further details about the event are not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-459639, MOD-2022-459640 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 24-year-old, female patient with no relevant medical history, who experienced the unexpected, non-serious, AESI event of COVID-19. The event occurred 1 week after the first dose of mRNA-1273 vaccine administered on an unknown date in Feb-21 for the indication of COVID-19 vaccination. SARS-CoV-2 test done on 15-Jun-21 was positive. At the time of report outcome of the event was Unknown. Further details about the event are not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
The patient was brought to the ED by EMS on 9/2/23 with 3-4 days of congestion, sore throat, productive cough, headache, and fever of 101.7 F. She had two at-home COVID tests which were both negative, however a COVID-19 PCR test performed in the ED resulted positive. The patient was admitted 9/2/23 - 9/5/23 with sepsis secondary to COVID-19 infection, among other diagnoses. Of note, the patient has received the primary COVID vaccine series and two boosters.
pt recvd vax;devel fever of 102 & cellulitis for 48 hrs;pt was immunized following injury;
Right thigh swollen to 32cm, no redness, no tenderness, no tenderness.
I woke up on Sunday, January 17 at 7:30 AM and noticed my lymph nodes on both sides of my neck were swollen. The left side was more swollen than the right side. The swelling is closer to my clavicle then higher on my neck. I am having no pain with the swelling and I have no temperature above normal.
Fever above 100, slight cough, not responding, wife could not get him out of bed, rapid weight loss, stomach pain
There were no adverse effects or symptoms at time of the event. Pt has been advised to f/u if there are any effects or side effects to the vaccination.
had the Pfizer Covid 19 vaccines and still got Covid.; had the Pfizer Covid 19 vaccines and still got Covid.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group.  A 74-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), on 17Mar2021 as dose 1, single (Lot number: ER6955), on 07Apr2021 as dose 2, single (Lot number: ER8732) and on 06Dec2021 as dose 3 (booster), single (Lot number: EW0191) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "had the Pfizer Covid 19 vaccines and still got Covid.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Caller states she and her husband had the Pfizer Covid 19 vaccines and still got Covid.  They are both taking Paxlovid. Therapeutic measures were taken as a result of vaccination failure, covid-19.
arm pain; flu like symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Lot number: EN6198) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm pain"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu like symptoms".  No follow-up attempts are possible. No further information is expected.
Information has been received from a Licensed Practical Nurse (L.P.N.) referring to multiple unspecified patients of unknown age and gender. Information regarding relevant history and concurrent condition were not reported. On multiple unspecified dates, the patients were vaccinated with improperly stored GARDASIL 9 (dose, lot # and route unspecified). Information regarding concomitant medications was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning a patient who on 30-NOV-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot #663889/0632Y). Subsequently, the patient had a huge area of Erythema, swelling and temperature of 101F. The patient ended up in the hospital (unspecified). The reporter reported that the patient's unspecified cultures were negative. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. No further information is available.
About 9 minutes after administration, pt reported a nickel taste. Initially strong, but it was subsiding by 15 minutes after the vaccination
Data exchange not properly working in EHR. Office procedure did not include immunization reconciliation causing extra dose to be given.
chills, extreme muscle & joint ache espectialy arthritic and nerve damage low back & leg  rt foot. violent vomititng with severe headache 2nd day, Nausea, low fever 100, extreme fatigue lasting more than 4 days
The morning after my first vaccination, I experienced extreme fatigue. I felt as if I did not sleep at all. I had a very painful injection site. I then proceeded to get full body chills and aches for the next 3 days. I had to take Tylenol around-the-clock to manage the symptoms. I felt like I had influenza. My second injection was similar simtoms as the first, but only for 1 day following the injection. Additionally, by the next night 9/9/2021, I had a temperature of 102.3ºF.
Injection site soreness; This is a spontaneous report received from a contactable consumer. A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection and lot number: EL 3247) via an unspecified route of administration in left arm on 22Feb2021 12:00 at single dose for COVID-19 immunization. Patient medical history included ADHD and Depression. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), multivitamin, fish oil and ademetionine (SAM-E). On 23Feb2021 05:30 patient experienced with Injection site soreness. Patient did not receive any treatment. Outcome of event was recovering.
about 4 minutes after vaccination: blurred vision, fast heart beat, shaking, high blood increased, throat was itchy, started coughing, voice went hoarse, headache, legs felt heavy.  put in a room and monitored for about an hour, glucose test done. took Benadryl when I got home.  felt like extremely fatigued/weak for 4 days.
severe fever, chills, convuls nausea, sweats, rash, blood in urine, liver function abn-possible hep being eval;Annual follow-up dated 12/18/00 provided no additional data.
Tingling, numbness, dry lips/mouth, tongue, puffy hands, sweaty hands.
3 yr old who developed hives, vomiting approx 30 mins after receiving his 3 vaccines, given BENADRYL given but child vomited again advised to call 911 seen at ED with resp sxs given epinephrine x 1 with improvement of symptoms - home on allergy med x 1 wk.
Increasing pain on left arm, swelling, muscle pain, joint pain, lightheadedness, headache, upset stomach, itching. A type of shingles developed on my left arm, going from shoulder all the way to the forearm: Hot, itchy, red.